The Registry of Toxic Effects of Chemical Substances
Cadmium sulfide |
UPDATE: May 2005 | MW: 144.46 | MF: CdS |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
human
leukocyte
|
62 µg/L
|
PJACAW 48,133,1972
|
DNA damage
|
hamster
ovary
|
10 mg/L
|
CRNGDP 3,657,1982
|
morphological transform
|
hamster
embryo
|
1 mg/L
|
CNREA8 42,2757,1982
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intramuscular | rat
lowest published toxic dose: 120 mg/kg
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Tumorigenic: Tumors at site of application
BJCAAI 20,190,1966
|
subcutaneous | rat
lowest published toxic dose: 90 mg/kg
|
Tumorigenic: Carcinogenic by RTECS criteria | Tumorigenic: Tumors at site of application
BJCAAI 20,190,1966
|
subcutaneous | rat
toxic dose : 135 mg/kg
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Tumorigenic: Tumors at site of application
PBPHAW 14,47,1978
|
subcutaneous | rat
toxic dose : 250 mg/kg
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Blood: Lymphoma including Hodgkin's disease Tumorigenic: Tumors at site of application
NATUAS 198,1213,1963
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | rat
lethal concentration : >140 mg/m3/2 hour
|
N/R
|
NTIS** OTS0539392
|
oral | mouse
lethal dose (50 percent kill): 1,166 mg/kg
|
N/R
|
41HTAH -,14,1978
|
oral | rat
lethal dose (50 percent kill): 7,080 mg/kg
|
N/R
|
41HTAH -,14,1978
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average 0.01 mg(Cd)/m3, inhalable dust
|
DTLVS* TLV/BEI,1999
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average 0.002 mg(Cd)/m3, respirable dust
|
DTLVS* TLV/BEI,1999
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
Suspected human carcinogen
|
DTLVS* TLV/BEI,1999
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 2,74,1973
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 11,39,1976
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 58,119,1993
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Sufficient Evidence
|
IMEMDT 58,119,1993
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 1
|
IMEMDT 58,119,1993
|
TOXICOLOGY REVIEW
|
|
FCTXAV 9,105,1971
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Mine Safety and Health Administration (MSHA) STANDARD - air
|
time-weighted average 0.2 mg(Cd)/m3
|
DTLVS* 3,34,1971
|
Occupational Exposure Limit - ARAB Republic of Egypt
|
time-weighted average 0.05 mg(Cd)/m3, JAN1993
|
Occupational Exposure Limit - AUSTRALIA
|
time-weighted average 0.05 mg(Cd)/m3, JAN1993
|
Occupational Exposure Limit - AUSTRIA
|
Carcinogen, JAN1999
|
Occupational Exposure Limit - BELGIUM
|
time-weighted average 0.05 mg(Cd)/m3, JAN1993
|
Occupational Exposure Limit - DENMARK
|
time-weighted average 0.01 mg(Cd)/m3, JAN1999
|
Occupational Exposure Limit - FINLAND
|
time-weighted average 0.02 mg(Cd)/m3, Carcinogen, Jan1999
|
Occupational Exposure Limit - FRANCE
|
VME 0.05 mg(Cd)/m3, JAN1999
|
Occupational Exposure Limit - GERMANY
|
Carcinogen, JAN1999
|
Occupational Exposure Limit - THE NETHERLANDS
|
MAC-TGG 0.005 mg(Cd)/m3, 2003
|
Occupational Exposure Limit - JAPAN
|
Occupational Exposure Limit 0.05 mg(Cd)/m3, Group 1 Carcinogen, JAN1999
|
Occupational Exposure Limit - NORWAY
|
time-weighted average 0.05 mg(Cd)/m3, JAN1999
|
Occupational Exposure Limit - THE PHILIPPINES
|
time-weighted average 0.2 mg(Cd)/m3, JAN1993
|
Occupational Exposure Limit - POLAND
|
MAC(time-weighted average) fume 0.02 mg(Cd)/m3, MAC(short term exposure limit) fume 0.05 mg(Cd)/m3, JAN1999
|
Occupational Exposure Limit - POLAND
|
MAC(time-weighted average) dust 0.04 mg(Cd)/m3, MAC(short term exposure limit) dust 0.2 mg(Cd)/m3, JAN1999
|
Occupational Exposure Limit - RUSSIA
|
time-weighted average 0.01 mg(Cd)/m3, short term exposure limit 0.05 mg(Cd)/m3, JAN1993
|
Occupational Exposure Limit - SWEDEN
|
Carcinogen, JAN1999
|
Occupational Exposure Limit - SWITZERLAND
|
MAK- week 0.05 mg(Cd)/m3, Carcinogen, JAN1999
|
Occupational Exposure Limit - THAILAND
|
time-weighted average 0.2 mg(Cd)/m3, short term exposure limit 0.5 mg(Cd)/m3, JAN1993
|
Occupational Exposure Limit - TURKEY
|
time-weighted average 0.2 mg(Cd)/m3, JAN1993
|
Occupational Exposure Limit - UNITED KINGDOM
|
time-weighted average 0.03 mg(Cd)/m3, SEP2000
|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value; | Suspected human carcinogen
Occupational Exposure Limit IN NEW ZEALAND, SINGAPORE, VIETNAM
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value |
Suspected human carcinogen |
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO CADMIUM, dust and fume-air
|
Carcinogen lowest feasible conc.
|
NIOSH* DHHS #92-100,1992
|
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 83628; | Number of Industries 29; Total Number of Facilities 1,041; Number of Occupations 41; Total Number of Employees Exposed 19,293
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 83628; |
Number of Industries 32; Total Number of Facilities 1,625; Number of Occupations 38; Total Number of Employees Exposed 42,562; Total Number of Female Employees Exposed 16,685 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat
|
EPA GENETOX PROGRAM 1988, Positive: In vitro cytogenetics-human lymphocyte
|
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used in pigments and as an active ingredient of shampoos
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NTP 11th Report on Carcinogens,2004:Known to be human carcinogen
|
|
REFERENCES:
CODEN
|
|
REFERENCE
41HTAH
|
"Aktual'nye Problemy Gigieny Truda. Current Problems of Labor Hygiene," Tarasenko, N.Y., ed.,
Moscow, Pervyi Moskovskii Meditsinskii Inst., 1978
|
BJCAAI
|
British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS,
UK) V.1- 1947-
|
CNREA8
|
Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA
19106) V.1- 1941-
|
CRNGDP
|
Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford
OX8 1JJ, UK) V.1- 1980-
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
FCTXAV
|
Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see
FCTOD7.
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
NATUAS
|
Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869-
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
NTIS**
|
National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse
for Scientific & Technical Information.
|
PBPHAW
|
Progress in Biochemical Pharmacology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland)
V.1- 1965-
|
PJACAW
|
Proceedings of the Japan Academy. (Tokyo, Japan) V.21-53, 1945-77. For publisher
information, see PJABDW.
|
|